What Researchers Did
Researchers retrospectively analyzed the clinical characteristics of 125 divers treated for decompression sickness (DCS) at the Israel Naval Medical Institute between 1992 and 1997.
What They Found
Of the 125 divers, 62 (51%) had DCS Type I and 60 (49%) had DCS Type II. Among the 112 patients with available results, 54 (48%) recovered completely, 54 recovered partially, and 4 did not respond to treatment. Inner ear DCS was less responsive to hyperbaric oxygen treatment (p = 0.0001), while significant neurological improvement was observed in those with severe neurological injury (p = 0.0001).
What This Means for Canadian Patients
Canadian divers experiencing decompression sickness could benefit from rapid diagnosis and transportation to a hyperbaric chamber for treatment. Prompt intervention is crucial for improving recovery outcomes, especially for neurological symptoms.
Canadian Relevance
This study was conducted in Israel and has no direct Canadian connection. However, the findings on decompression sickness treatment are generally applicable to diving communities worldwide, including Canada.
Study Limitations
The study was a retrospective analysis from a single institute, and complete follow-up data was not available for all patients.